儿童神经代谢病质子MRS标准化呼吁与简易方案
本文针对临床儿童质子磁共振波谱采集与后处理缺乏统一标准的问题,由波谱专家联合肌酸缺乏症协会提出一套最低标准单 voxel 质子 MRS 方案。该方案可用于快速评估疑似遗传性神经发育迟缓患儿,并强调脑肌酸定量对肌酸缺乏综合征诊断、治疗监测及临床试验设计的重要性。
要点
- 儿童脑肌酸缺乏综合征易被误诊,延迟补充治疗可影响预后。
- 建议采用最低标准单 voxel 质子 MRS 方案以提高各机构间可比性。
- 脑肌酸定量信息可用于诊断、治疗反应监测及指导未来临床试验。
核心结论
- 呼吁在儿童神经代谢病临床检查中推广标准化单 voxel 质子 MRS 采集与后处理方法。
- 提出的最低标准方案可作为新开展或已开展 MRS 机构的起点或补充。
研究设计与样本
- 本文为专家建议性文件,由波谱专家与肌酸缺乏症协会领导层于 2024 年底启动讨论后形成。
- 专家团队回顾文献、识别跨厂商共同参数,并制定可用于临床的最低标准单 voxel 质子 MRS 方案。
关键影像表现/征象
- 脑肌酸浓度定量信息可用于表征肌酸缺乏综合征并追踪治疗相关生物标志物。
- 不同影像机构间质子 MRS 采集、后处理及解读存在明显变异性。
诊断标准与关键数值
- 推荐采用单 voxel 质子 MRS 作为最低标准方案,用于快速评估符合遗传病因的神经发育迟缓患儿。
临床应用与阅片要点
- 影像科可采用该最低标准方案提高儿童神经代谢病 MRS 报告的规范性和可比性。
- 遇到疑似遗传性神经发育迟缓患儿时,应注意评估脑肌酸相关代谢物并避免漏诊肌酸缺乏综合征。
局限性
- 该文为专家意见与实施建议,未报告具体样本量、诊断敏感度或特异度等验证数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: There is a pressing demand to implement a standard acquisition and post-processing approach for proton magnetic resonance spectroscopy performed in children within the clinical setting. Clinical magnetic resonance spectroscopy data is needed to characterize and understand phenotypes and track treatment response, especially in rare genetic disorders with distinct metabolite signatures. For instance, infants and children with cerebral creatine deficiency syndromes are too often misdiagnosed, which leads to delay in life-changing supplementation especially for those with synthesis deficiencies. Quantitative information about brain creatine concentrations is useful in characterizing these syndromes, potentially tracking relevant biomarkers in relation to treatment response, and guiding future clinical trial designs for patients.
METHODS: Spectroscopists began discussions about the usage of magnetic resonance spectroscopy in late 2024 with the leadership of the Association for Creatine Deficiencies (ACD). The ACD is a charitable organization established by parents of children with creatine deficiencies to provide patient, family, and public education, to advocate for early intervention through newborn screening, and to promote and fund medical research for treatments and cures for Cerebral Creatine Deficiency Syndromes. The ACD hosts a patient registry where families complete surveys and upload medical reports. Upon review of radiologist reports, the group noted the variability in acquisition, post-processing and interpretation across patient studies and clinical imaging sites. A team of spectroscopists reviewed the literature, identified common parameters across vendors and developed a harmonized approach that can serve as a starting point for imaging sites adopting magnetic resonance spectroscopy or a supplement to those already using it.
KEY MESSAGE: This paper is a call for the usage and provides a recommendation of a minimum standard single voxel proton magnetic resonance spectroscopy approach that can be implemented for rapidly evaluating pediatric patients with neurodevelopmental delays consistent with genetic etiologies.
引用
- Cecil, Henry, Wallis, et al. A Call for Pediatric Magnetic Resonance Spectroscopy Harmonization in Neurometabolic Disorders with a Simple Approach for Diagnosis, Treatment Monitoring and Data Aggregation for Clinical Trials. AJNR Am J Neuroradiol. 2026. PMID: 42680585. doi:10.3174/ajnr.A9618
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。